Aerospace Safety Advisory Panel; Charter Renewal, 65750-65751 [2011-27407]

Download as PDF 65750 Federal Register / Vol. 76, No. 205 / Monday, October 24, 2011 / Notices the basic classes of controlled substances listed. Dated: October 3, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–27430 Filed 10–21–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated June 7, 2011, and published in the Federal Register on June 16, 2011, 76 FR 35243, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug tkelley on DSK3SPTVN1PROD with NOTICES Dated: October 3, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. (Pub. L. 94–409) (5 U.S.C. 552b) [FR Doc. 2011–27424 Filed 10–21–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE I Advisory Board Meeting Time and Date: 8 a.m. to 4:30 p.m. on Wednesday, November 2, 2011, 8 a.m. to 4:30 p.m. on Thursday, November 3, 2011. Place: Stanford University Law School, 550 Nathan Abbott Way, Stanford, California, (650) 724–6258. Matters To Be Considered: Organizational culture and change in the correctional environment; Performance Based Outcomes; Director’s report; Presentations. Contact Person for More Information: Thomas Beauclair, Deputy Director, 202–307–3106, ext. 44254. I I II II II II II II II II II II II II II II II II Morris L. Thigpen, Director. [FR Doc. 2011–27157 Filed 10–21–11; 8:45 am] BILLING CODE 4410–36–M II II II II II II Jkt 226001 DEPARTMENT OF JUSTICE United States Parole Commission Sunshine Act Meeting; Record of Vote of Meeting Closure I, Isaac Fulwood, of the United States Parole Commission, was present at a meeting of said Commission, which started at approximately 11 a.m., on Thursday, September 8, 2011, at the U.S. Parole Commission, 90 K Street, PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 In witness whereof, I make this official record of the vote taken to close this meeting and authorize this record to be made available to the public. Dated: September 15, 2011. Isaac Fulwood, Chairman, U.S. Parole Commission. [FR Doc. 2011–27571 Filed 10–20–11; 4:15 pm] National Institute of Corrections I I I I I The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of 15:34 Oct 21, 2011 NE., Third Floor, Washington, DC 20530. The purpose of the meeting was to discuss four original jurisdiction cases pursuant to 28 CFR 2.27. Four Commissioners were present, constituting a quorum when the vote to close the meeting was submitted. Public announcement further describing the subject matter of the meeting and certifications of the General Counsel that this meeting may be closed by votes of the Commissioners present were submitted to the Commissioners prior to the conduct of any other business. Upon motion duly made, seconded, and carried, the following Commissioners voted that the meeting be closed: Isaac Fulwood, Cranston J. Mitchell, Patricia Cushwa and J. Patricia Wilson Smoot. Schedule Gamma Hydroxybutyric Acid (2010). Ibogaine (7260) ............................ Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... Dimethyltryptamine (7435) ........... 1-[1-(2-Thienyl) cyclohexyl] piperidine (7470). Dihydromorphine (9145) ............... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Amobarbital (2125) ....................... Phencyclidine (7471) .................... Phenylacetone (8501) .................. Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Heroin (9200) ............................... Meperidine (9230) ........................ Metazocine (9240) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273). Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Phenazocine (9715) ..................... Fentanyl (9801) ............................ VerDate Mar<15>2010 American Radiolabeled Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated American Radiolabeled Chemicals Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. BILLING CODE 4410–01–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [Notice (11–105)] Aerospace Safety Advisory Panel; Charter Renewal National Aeronautics and Space Administration (NASA). ACTION: Notice of renewal and amendment of the charter of the NASA Aerospace Safety Advisory Panel. AGENCY: Pursuant to sections 14(b)(1) and 9(c) of the Federal Advisory Committee Act (Pub. L. 92–463), and after consultation with the Committee Management Secretariat, General Services Administration, the NASA Administrator has determined that a renewal and amendment of the charter of the NASA Aerospace Safety Advisory Panel is in the public interest in connection with the performance of duties imposed on NASA by law. The renewed charter is for a two-year period ending October 13, 2013. It is identical to the previous charter in all respects except it removes references to areas of responsibility that are no longer applicable, updates legal citations, and conforms the text to the most recent Congressional reauthorization for this Federal advisory committee (Pub. L. 111–314 on December 18, 2010). SUMMARY: E:\FR\FM\24OCN1.SGM 24OCN1 Federal Register / Vol. 76, No. 205 / Monday, October 24, 2011 / Notices Ms. Susan M. Burch, Advisory Committee Management Division, Office of International and Interagency Relations, (202) 358–0550, National Aeronautics and Space Administration, Washington, DC 20546–0001. FOR FURTHER INFORMATION CONTACT: October 18, 2011. P. Diane Rausch, Advisory Committee Management Officer, National Aeronautics and Space Administration. [FR Doc. 2011–27407 Filed 10–21–11; 8:45 am] BILLING CODE 7510–13–P NATIONAL AERONAUTICS AND SPACE ADMINISTRATION the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. ADDRESSES: Objections relating to the prospective license may be submitted to Mr. James J. McGroary, Chief Patent Counsel/LS01, Marshall Space Flight Center, Huntsville, AL 35812, (256) 544–0013. FOR FURTHER INFORMATION CONTACT: Sammy A. Nabors, Technology Transfer Office/ED10, Marshall Space Flight Center, Huntsville, AL 35812, (256) 544–5226. Information about other NASA inventions available for licensing can be found online at https:// technology.nasa.gov. Dated: October 18, 2011. Richard W. Sherman, Deputy General Counsel. [Notice 11–102] Notice of intent to grant exclusive license [FR Doc. 2011–27465 Filed 10–21–11; 8:45 am] National Aeronautics and Space Administration. ACTION: Notice of intent to grant exclusive license. BILLING CODE 7510–13–P This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the invention described and claimed in MFS–32870–1 ‘‘Greener ElectroMechanical Slide Valve’’ to QM Power, Inc, having its principal place of business in Lee’s Summit, MO. The intellectual property rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. NASA has not yet made a determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period. DATES: The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated exclusive license. Objections submitted in response to this notice will not be made available to [Notice (11–103)] AGENCY: tkelley on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:34 Oct 21, 2011 Jkt 226001 NATIONAL AERONAUTICS AND SPACE ADMINISTRATION Notice of intent to grant exclusive license National Aeronautics and Space Administration. ACTION: Notice of intent to grant exclusive license. AGENCY: This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant an exclusive license in the United States to practice the inventions described and claimed in U.S. Patent No. 7,341,883 B2 entitled ‘‘Silicon Germanium Semiconductive Alloy and Method of Fabricating Same,’’ U.S. Patent No. 7,514,726 B2 entitled ‘‘Graded Index Silicon Germanium on Lattice Matched Silicon Germanium Semiconductive Alloy,’’ U.S. Patent No. 7,558,371 B2 entitled ‘‘Method of Generating X–Ray Diffraction Data for Integral Detection of Twin Defects in Super-Hetero-Epitaxial Materials,’’ U.S. Patent No. 7,906,358 B2 entitled ‘‘Epitaxial Growth of Cubic Crystalline Semiconductor Alloys on Basal Plane of Trigonal or Hexagonal Crystal,’’ U.S. Patent Application No. 12/254,134 entitled ‘‘Hybrid Bandgap Engineering for Super-Hetero-Epitaxial Semiconductor Materials, and Products Thereof,’’ U.S. Patent Application No. 12/288,379 entitled ‘‘Rhombohedral Cubic Semiconductor Materials on Trigonal Substrate with Single Crystal Properties and Devices Based on Such Materials,’’ U.S. Patent No. 7,769,135 B2 SUMMARY: PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 65751 entitled ‘‘X-ray Diffraction Wafer Mapping Method for Rhombohedral Super-Hetero-Epitaxy; and U.S. Patent Application No. 12/254,016 entitled ‘‘Thermoelectric Materials and Devices,’’ to innoEpi Incorporated having its principal place of business in Santa Clara, California. The patent rights in these inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. DATES: Objections relating to the prospective license may be submitted to Patent Attorney, Office of Chief Counsel, NASA Langley Research Center, MS 30, Hampton, VA 23681; (757) 864–5057 (phone), (757) 864–9190 (fax). ADDRESSES: FOR FURTHER INFORMATION CONTACT: Thomas K. McBride Jr., Patent Attorney, Office of Chief Counsel, NASA Langley Research Center, MS 30, Hampton, VA 23681; (757) 864–5057; Fax: (757) 864– 9190. Information about other NASA inventions available for licensing can be found online at https:// technology.nasa.gov. Dated: October 18, 2011. Richard W. Sherman, Deputy General Counsel. [FR Doc. 2011–27464 Filed 10–21–11; 8:45 am] BILLING CODE 7510–13–P E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

National Aeronautics and Space Administration

[Federal Register Volume 76, Number 205 (Monday, October 24, 2011)]
[Notices]
[Pages 65750-65751]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27407]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (11-105)]


Aerospace Safety Advisory Panel; Charter Renewal

AGENCY: National Aeronautics and Space Administration (NASA).

ACTION: Notice of renewal and amendment of the charter of the NASA 
Aerospace Safety Advisory Panel.

-----------------------------------------------------------------------

SUMMARY: Pursuant to sections 14(b)(1) and 9(c) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and after consultation with the 
Committee Management Secretariat, General Services Administration, the 
NASA Administrator has determined that a renewal and amendment of the 
charter of the NASA Aerospace Safety Advisory Panel is in the public 
interest in connection with the performance of duties imposed on NASA 
by law. The renewed charter is for a two-year period ending October 13, 
2013. It is identical to the previous charter in all respects except it 
removes references to areas of responsibility that are no longer 
applicable, updates legal citations, and conforms the text to the most 
recent Congressional reauthorization for this Federal advisory 
committee (Pub. L. 111-314 on December 18, 2010).

[[Page 65751]]


FOR FURTHER INFORMATION CONTACT: Ms. Susan M. Burch, Advisory Committee 
Management Division, Office of International and Interagency Relations, 
(202) 358-0550, National Aeronautics and Space Administration, 
Washington, DC 20546-0001.

    October 18, 2011.
P. Diane Rausch,
Advisory Committee Management Officer, National Aeronautics and Space 
Administration.
[FR Doc. 2011-27407 Filed 10-21-11; 8:45 am]
BILLING CODE 7510-13-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.